Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Mol Pharmacol ; 62(2): 297-303, 2002 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12130681

RESUMO

Glucocorticoids are potent anti-inflammatory and immunosuppressant agents. However, they also produce serious side effects that limit their usage. It has been proposed that anti-inflammatory properties of glucocorticoids are caused mostly by repression of activator protein 1- and nuclear factor kappabeta-stimulated synthesis of inflammatory mediators, whereas most of their adverse effects are associated with trans-activation of genes involved with metabolic processes. Our laboratories have sought to discover novel glucocorticoid receptor (GR) ligands that have high repression but low trans-activation activities. We describe here cellular properties of 2,5-dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5-(1-methylcyclohexen-3-y1)-1H-[1]benzopyrano[3,4-f]quinoline (A276575) and its four enantiomers. Similar to dexamethasone, A276575 exhibited high affinity for GR and potently repressed interleukin (IL) 1beta-stimulated IL-6 production in human skin fibroblasts, prostaglandin (PG) E(2) production in A549 human lung epithelial cells, and concanavalin A-induced monocyte proliferation. In contrast to dexamethasone, A276575 caused smaller induction of aromatase activity in human skin fibroblasts and antagonized dexamethasone-induced activation of an mouse mammary tumor virus-glucocorticoid-response element (GRE) reporter gene construct. Among the four enantiomers of A276575, the two (-)-enantiomers showed 10- to 30-fold higher affinities for GR than their respective (+)-enantiomers. Both (-)-Syn and (-)-Anti enantiomers of A276575 were potent inhibitors of IL-1beta-stimulated PGE2 production in A549 lung epithelial cells; unexpectedly, however, only the (-)-Anti enantiomer inhibited regulated on T-cell activation, normal T-cell expressed and secreted (RANTES) production in A549 cells. In summary, A276575 is a novel, nonsteroidal GR ligand that possesses high repression activities against inflammatory mediator production but has lower GRE trans-activation activities than traditional steroids. Differential repression of RANTES and PGE2 production in a cell by the two (-)-enantiomers of A276575 illustrates the complexity of repression by GR.


Assuntos
Benzopiranos/farmacologia , Inativação Gênica/efeitos dos fármacos , Quinolinas/farmacologia , Receptores de Glucocorticoides/antagonistas & inibidores , Ativação Transcricional/efeitos dos fármacos , Aromatase/metabolismo , Benzopiranos/química , Divisão Celular/efeitos dos fármacos , Quimiocina CCL5/metabolismo , Concanavalina A/farmacologia , Dinoprostona/metabolismo , Interações Medicamentosas , Fibroblastos/efeitos dos fármacos , Fibroblastos/enzimologia , Humanos , Interleucina-1/farmacologia , Interleucina-6/metabolismo , Leucócitos Mononucleares/citologia , Vírus do Tumor Mamário do Camundongo/genética , Quinolinas/química , Receptores de Glucocorticoides/agonistas , Receptores de Glucocorticoides/química , Receptores de Glucocorticoides/genética , Receptores de Progesterona/agonistas , Receptores de Progesterona/antagonistas & inibidores , Pele/efeitos dos fármacos , Pele/enzimologia , Estereoisomerismo , Transfecção
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA